YBX1 and systemic sclerosis: Jeoung et al. applied recombinant GST-YB-1 to determine autoantibody frequency in rheumatic diseases, with systemic sclerosis showing the highest prevalence (44%) followed by SLE (14%), whereas healthy controls mostly had no autoantibodies (7%).